Twenty-six years later Susan G. Komen for the Cure® can point to some significant victories in the fight against breast cancer, investing over $1 billion to fulfill that promise; today the five year survival rate is 98 percent and nearly 70 percent of women over 40 receive regular mammograms.
But the fierce fight against the disease must continue. Consider these facts:
Breast cancer is still the most prevalent cancer in the world today
A woman dies from breast cancer every 75 seconds worldwide
Over the next 25 years, another 25 million women and men are expected to be diagnosed with breast cancer and 10 million will die of the disease
In the U.S., a woman has a 1 in 8 risk of developing breast cancer in her lifetime
As the largest nonprofit source of funds dedicated to fight breast cancer, Komen for the Cure® continues to push for the advances in science that will ultimately defeat the disease. For instance, science has discovered that two inherited gene mutations, BRCA1 and BRCA2, greatly increase the risk of developing breast cancer. Researchers estimate that 250,000 women in the United States carry a BRCA1 or BRCA2 gene mutation. A woman's odds of developing breast cancer is about 58 to 80 percent if she has the BRCA1 mutation and about 30 to 85 percent if she carries the BRCA2 mutation.
Komen knows science can and will save lives, and is committed to invest an additional $2 billion over the next 25 years to fulfill the promise to find a cure. As a testament to the power of society and science to save lives, more than 2.3 million breast cancer survivors live in the U.S today.
How will you help? To learn more about Komen's research efforts, to donate or to learn how you can volunteer with Komen, please call 216.292.CURE or visit www.komenneohio.org.